Chemical Name: [1-[[(5R)-2-[4-(5-Chloropyrimidin-2-yl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]cyclobutyl]methanol. Alternate Names: BI 1015550
PDE4B inhibitor
Molekulargewicht:
448.97
Reinheit:
>98% by HPLC NMR (Conforms)
Formulierung:
White solid
CAS Nummer:
[1423719-30-5]
Formel:
C20H25ClN6O2S
Anwendungsbeschreibung:
Nerandomilast is a potent and selective inhibitor of phosphodiesterase 4B (IC50s: PDE4A = 248 nM, PDE4B = 10 nM, PDE4C = 8,700 nM, PDE4D = 91 nM, PDE7A = 14 µM, PDE3A = 120 µM, PDE1C = 46 µM).1 It inhibited TNFalpha release (IC50 = 35 nM) and IL-2 release (IC50 = 9 nM) in human PBMCs. Nerandomilast has potent anti-inflammatory activity and displayed efficacy in mouse models of lung fibrosis.1,2 Approved for the treatment of idiopathic pulmonary fibrosis.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten